Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Daniel Abate-Daga
Introduction
Daniel Abate-Daga is a prominent inventor based in Tampa, FL, known for his significant contributions to cancer treatment through innovative research and development. With a total of 6 patents to his name, he has made remarkable strides in the field of immunotherapy, particularly in the development of CAR T-cell therapies.
Latest Patents
Among his latest patents, one notable invention is focused on CAR T-cells for the treatment of bone metastatic cancer. This method involves co-administering a gamma-delta T cell stimulating agent along with a γδ CAR T cell that targets specific tumor antigens, such as those associated with prostate and breast cancers. Another significant patent involves IL13Ra2-binding chimeric antigen receptors, which are designed to target and eliminate IL13Ra2-expressing cancers. These advancements highlight his commitment to enhancing anti-cancer immunity through innovative cellular therapies.
Career Highlights
Daniel Abate-Daga is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he collaborates with leading experts in the field. His work has been instrumental in advancing the understanding and application of CAR T-cell technology in clinical settings. His research not only contributes to scientific knowledge but also aims to improve patient outcomes in cancer treatment.
Collaborations
Throughout his career, Daniel has worked alongside esteemed colleagues such as James Liu and Alan F List. These collaborations have fostered a dynamic research environment that encourages innovation and the sharing of ideas, ultimately leading to groundbreaking advancements in cancer therapies.
Conclusion
Daniel Abate-Daga's contributions to the field of cancer treatment through his innovative patents and collaborative efforts exemplify the impact of dedicated research in improving patient care. His work continues to inspire advancements in immunotherapy and offers hope for more effective cancer treatments in the future.